Genetic modification of cultured skin substitutes by transduction of human keratinocytes and fibroblasts with platelet-derived growth factor-A

Wound Repair and Regeneration

Volumn 8, Issue 1, 2000, Pages 26-35

  Supp, Dorothy M ^a   Bell, Sheila M ^d   Morgan, Jeffrey R ^b   Boyce, Steven T ^a,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GLYCOSAMINOGLYCAN; PLATELET DERIVED GROWTH FACTOR A;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; EPIDERMIS CELL; FIBROBLAST; FULL THICKNESS SKIN GRAFT; GENE OVEREXPRESSION; GENE THERAPY; GENETIC ENGINEERING; HUMAN; HUMAN TISSUE; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CULTURE; WOUND HEALING;

ANIMALS; BLOTTING, SOUTHERN; CELLS, CULTURED; FEASIBILITY STUDIES; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; TRANSDUCTION, GENETIC;

EID: 0034049688     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.2000.00026.x     Document Type: Article

References (24)

1. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 1993;166:74-81.
2. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing: single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989;84:640-6.
3. Brown RL, Breeden MP, Greenhalgh DG. PDGF and TGF-α act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res 1994;56:562-70.
4. Greenhalgh DA, Rothnagel JA, Roop DR. Epidermis: an attractive target tissue for gene therapy. J Invest Dermatol 1994;103:63S-69S.
5. Eming SA, Whitsitt JS, He L, Krieg T, Morgan JR, Davidson JM. Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol 1999;112:297-302.
6. Liechty KW, Nesbit M, Herlyn M, Radu A, Adzick NS, Crombleholme TM. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 1999;113:375-83.
7. Heldin C-H, Westermark B. Role of platelet-derived growth factor in vivo. In Clark RAF, editor. The molecular and cellular biology of wound repair. New York, Plenum Press, 1996:249-73.
8. Ansel JC, Tiesman JP, Olerud JE, Krueger JG, Krane JF, Tara DC, Shipley GD, Gilbertson D, Usui ML, Hart CE. Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Invest 1993;92:671-8.
9. Beer H-D, Longaker MT, Werner S. Reduced expression of PDGF and PDGF receptors during impaired wound healing. J Invest Dermatol 1997;109:132-8.
10. Eming SA, Lee J, Snow RG, Tompkins RG, Yarmush ML, Morgan JR. Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice - implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dermatol 1995;105:756-63.
11. Eming SA, Medalie DA, Tompkins RG, Yarmush ML, Morgan JR. Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 1998;9:529-39.
12. Boyce ST, Greenhalgh DG, Kagan RJ, Housinger T, Sorrell JM, Childress CP, Rieman M, Warden GD. Skin anatomy and antigen expression after burn wound closure with composite grafts of cultured skin cells and biopolymers. Plast Reconstruct Surg 1993;91:632-41.
13. Boyce ST, Goretsky MJ, Greenhalgh DG, Kagan RJ, Rieman MT, Warden GD. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg 1995;222:743-52.
14. Harriger MD, Warden GD, Greenhalgh DG, Kagan RJ, Boyce ST. Pigmentation and microanatomy of skin regenerated from composite grafts of cultured cells and biopolymers applied to full-thickness burn wounds. Transplantation 1995;59:702-7.
15. Boyce ST, Glatter R, Kitzmiller WJ. Treatment of chronic wounds with cultured skin substitutes: a pilot study. Wounds 1995;7:24-9.
16. Boyce ST, Kagan RJ, Meyer NA, Yakuboff K, Warden GD. The 1999 Clinical Research Award: Cultured skin substitutes combined with Integra® to replace native skin autograft and allograft for closure of full-thickness burns. J Burn Care Rehab 1999;20:453-61.
17. Boyce ST, Ham RG. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serumfree media. J Tissue Cult Meth 1985;9:83-93.
18. Boyce ST, Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 1983;81 (Suppl.):33-40.
19. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988;85:6460-4.
20. Boyce ST, Foreman TJ, English KB, Stayner N, Cooper ML, Sakabu S, Hansbrough JF. Skin wound closure in athymic mice with cultured human cells, biopolymers, and growth factors. Surgery 1991;110:866-76.
21. Boyce ST. Methods for the serum-free culture of keratinocytes and transplantation of collagen-GAG-based skin substitutes. In: Morgan JR, Yarmush ML, editors. Methods in molecular medicine: tissue engineering methods and protocols. Totowa, NJ, Humana Press, Inc., 1998: 365-89.
22. Sadelain M. Methods for retrovirus-mediated gene transfer into primary T-lymphocytes. In: Robbins PD, editor. Methods in molecular medicine: gene therapy protocols. Totowa, NJ, Humana Press, Inc., 1997: 241-8.
23. Eming SA, Morgan JR. Methods for the use of genetically modified keratinocytes in gene therapy. In: Robbins PD, editor. Methods in molecular medicine: gene therapy protocols. Totowa, NJ, Humana Press, Inc., 1997: 265-79.
24. Supp DM, Supp AP, Bell SM, Boyce ST. Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor. J Invest Dermatol 1999; 2000;114:5-13.